Multi-Division PCD Pharma Franchise · WHO-GMP Certified · Telephone: +91 97658 93730 · Submit Application
Carbapenem + Renal Dehydropeptidase Inhibitor · Critical Care

IMIFRIL-CI

Imipenem 500mg + Cilastatin 500mg Injection

Carbapenem with cilastatin protection — broad-spectrum coverage for severe polymicrobial infections.

Enquire / Get Quote   WhatsApp Enquiry

At a Glance

Product Specifications

Brand NameIMIFRIL-CI
Generic / CompositionImipenem (as monohydrate) IP 500mg + Cilastatin Sodium IP equivalent to Cilastatin 500mg
Therapeutic CategoryCarbapenem + Renal Dehydropeptidase Inhibitor
Dosage FormLyophilized powder for injection
Strength500mg + 500mg
Route of AdministrationIntravenous infusion
Pack Size1 Vial with WFI
StorageStore below 25°C. Protect from light.
ManufacturerBiofril Healthcare Pvt. Ltd. · WHO-GMP Plant, Nalagarh HP
Prescription StatusRx — To be sold by retail on the prescription of a Registered Medical Practitioner
Clinical Use

Indications & Clinical Applications

IMIFRIL-CI is indicated for severe infections caused by susceptible bacteria, particularly in hospitalized patients where polymicrobial coverage is needed.

  • Severe lower respiratory tract infections
  • Complicated intra-abdominal infections
  • Gynaecologic and pelvic infections
  • Septicaemia and bacterial endocarditis
  • Skin and soft tissue infections
  • Bone and joint infections
Why Biofril IMIFRIL-CI

Product Features

  • Cilastatin prevents renal degradation, ensures adequate urinary levels
  • Broad-spectrum carbapenem
  • WHO-GMP manufactured
  • Suitable for ICU empirical therapy
Safety Information

Warnings & Precautions

Use with caution in CNS disorders (seizure risk). Adjust dose in renal impairment. Avoid in patients with hypersensitivity to beta-lactams or amide local anaesthetics.

This information is intended for healthcare professionals only. Always consult the complete product insert and a registered medical practitioner before prescribing or using. Biofril Healthcare is committed to pharmacovigilance — please report any adverse events to biofrilhealthcare@gmail.com.

Enquire About IMIFRIL-CI

PCD franchise · Hospital tenders · Bulk supply · Distribution opportunities

Get Quote & Net Rate   Call +91 97658 93730   WhatsApp

← Back to Critical Care Range  |  Critical Care PCD Franchise →